§ 1528.1. — 1528.1. (Added by Stats. 2025, Ch. 448, Sec. 1.)

(a)
If a client diagnosed with seizures, a seizure disorder, or epilepsy has been prescribed intranasal emergency antiseizure medication by their health care provider, a licensee may, upon receipt of a request from the client or client’s authorized representative, allow an administrator or authorized volunteer to administer intranasal emergency antiseizure medication to the client during a seizure emergency.
(b)
(1)
An administrator or authorized volunteer may administer intranasal emergency antiseizure medication in accordance with this article to a client diagnosed with seizures, a seizure disorder, or epilepsy if the client
is suffering from a seizure, as outlined in the client’s seizure action plan.
(2)
An administrator or authorized volunteer shall not administer intranasal emergency antiseizure medication unless they have received the training described in Section 1528.2.
(3)
Intranasal emergency antiseizure medication shall not be administered to a client unless the licensee has a seizure action plan for the client pursuant to Section 1528.3.
(c)
An administrator or authorized volunteer may rescind their offer to administer intranasal emergency
antiseizure medication at any time, including after receiving training, without penalty or retaliation.
(d)
A licensee shall adopt policies to implement this article that, among other things, ensure that any administration of intranasal emergency antiseizure medication pursuant to this article complies with the conditions specified in a client’s seizure action plan.

Legislative History

Added by Stats. 2025, Ch. 448, Sec. 1. (AB 1172) Effective January 1, 2026.